Valor20202021202220232024TTMGastos comerciales, generales y administrativos——————Investigación y desarrollo——————Beneficio operativo——————Total de ingresos no operativos——————Gastos por intereses, netos de intereses capitalizados——————Ingresos no operativos, una vez deducidos los gastos por intereses——————Ingresos/gastos extraordinarios——————Beneficio antes de impuestos——————Participación en los beneficios——————Impuestos——————Participación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas——————Operaciones suspendidas——————Beneficio neto——————Ajuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas——————Beneficio básico por acción——————Beneficio por acción diluido——————Número medio de acciones ordinarias——————Acciones diluidas——————EBITDA——————EBIT——————Costo de los ingresos——————Otros costes de producción——————Amortización y depreciación (flujo de caja)——————
Aurora Cannabis Inc
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.
After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO.